r attempts to delay or cancel deliveries under the order,
whether we encounter difficulties in making the cards, whether there are
quality or other issues which cause the end customer to delay its
acceptance of the cards and therefore our revenue recognition as well as
the risk factors detailed in the Company's Form 8-K, 10-K, and 10-Q filings
with the Securities and Exchange Commission. Due to these and other risks,
future actual results could differ materially from the Company's
expectations. These forward-looking statements speak only as to the date of
this release, and, except as required by law, the Company undertakes no
obligation to publicly release updates or revisions to these statements
whether as a result of new information, future events, or otherwise.
'/>"/>SOURCE LaserCard Corporation Copyright©2007 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology news :1.
Wiley announces publication of Databasing the Brain2.
Nonlinear Dynamics announces more details of its global partnership with PerkinElmer3.
FDA Announces Series of Changes to the Class of Marketed Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)4.
Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis5.
Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease6.
Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer7.
GlycoFi announces the first production of antibodies with human glycosylation in yeast8.
NHGRI announces new sequencing targets9.
CHAVI announces international search for genes affecting HIV response10.
NHGRI announces latest sequencing targets11.
MUHC announces a transplant first in Quebec